| Crinetics Pharmaceuticals, Inc. | 6,844 | US$572K | 2.8% |
| Mbx Biosciences, Inc. | 7,580 | US$500K | 2.4% |
| Ataibeckley Inc. | 62,140 | US$446K | 2.2% |
| Definium Therapeutics, Inc. | 9,353 | US$440K | 2.1% |
| Amylyx Pharmaceuticals, Inc. | 17,451 | US$354K | 1.7% |
| Enliven Therapeutics, Inc. | 6,348 | US$348K | 1.7% |
| Corcept Therapeutics Incorporated | 3,007 | US$344K | 1.7% |
| Alumis Inc. | 11,709 | US$331K | 1.6% |
| Nuvation Bio Inc. | 51,286 | US$325K | 1.6% |
| Trevi Therapeutics, Inc. | 17,529 | US$320K | 1.5% |
| Liquidia Corporation | 3,600 | US$303K | 1.5% |
| Nektar Therapeutics | 4,138 | US$292K | 1.4% |
| Amneal Pharmaceuticals, Inc. | 15,331 | US$281K | 1.4% |
| Bristol-myers Squibb Company | 4,226 | US$276K | 1.3% |
| Edgewise Therapeutics, Inc. | 7,137 | US$274K | 1.3% |
| Omeros Corporation | 23,028 | US$273K | 1.3% |
| Ligand Pharmaceuticals Incorporated | 947 | US$272K | 1.3% |
| Elanco Animal Health Incorporated | 10,270 | US$271K | 1.3% |
| Veradermics, Incorporated | 2,526 | US$265K | 1.3% |
| Pacira Biosciences, Inc. | 10,029 | US$265K | 1.3% |
| Viatris Inc. | 14,896 | US$262K | 1.3% |
| Jazz Pharmaceuticals Plc | 1,023 | US$259K | 1.3% |
| Eton Pharmaceuticals, Inc. | 5,548 | US$258K | 1.2% |
| Maze Therapeutics, Inc. | 9,551 | US$257K | 1.2% |
| Merck & Company, Inc. | 1,972 | US$257K | 1.2% |
| Harrow, Inc. | 6,543 | US$254K | 1.2% |
| Johnson & Johnson | 985 | US$253K | 1.2% |
| Royalty Pharma Plc | 4,308 | US$252K | 1.2% |
| Indivior Pharmaceuticals, Inc. | 6,167 | US$247K | 1.2% |
| Prestige Consumer Healthcare Inc. | 4,781 | US$240K | 1.2% |
| Collegium Pharmaceutical, Inc. | 6,750 | US$239K | 1.2% |
| Organon & Co. | 17,557 | US$238K | 1.2% |
| Eli Lilly And Company | 206 | US$237K | 1.1% |
| Eyepoint, Inc. | 19,051 | US$233K | 1.1% |
| Harmony Biosciences Holdings, Inc. | 6,619 | US$233K | 1.1% |
| Supernus Pharmaceuticals, Inc. | 5,209 | US$232K | 1.1% |
| Pfizer, Inc. | 9,176 | US$229K | 1.1% |
| Wave Life Sciences Ltd. | 41,500 | US$229K | 1.1% |
| Phibro Animal Health Corporation | 6,294 | US$229K | 1.1% |
| Ani Pharmaceuticals, Inc. | 2,870 | US$227K | 1.1% |
| Tarsus Pharmaceuticals, Inc. | 3,832 | US$226K | 1.1% |
| Zoetis Inc. | 2,889 | US$223K | 1.1% |
| Ocular Therapeutix, Inc. | 26,875 | US$220K | 1.1% |
| Xeris Biopharma Holdings, Inc. | 27,065 | US$219K | 1.1% |
| Rapport Therapeutics, Inc. | 5,313 | US$218K | 1.1% |
| Innoviva, Inc. | 10,214 | US$214K | 1.0% |
| Perrigo Company Plc | 21,029 | US$213K | 1.0% |
| Axsome Therapeutics, Inc. | 953 | US$208K | 1.0% |
| Amphastar Pharmaceuticals, Inc. | 9,545 | US$190K | 0.92% |
| Arvinas, Inc. | 23,099 | US$185K | 0.90% |
| Alto Neuroscience, Inc. | 6,833 | US$185K | 0.90% |
| Septerna, Inc. | 4,553 | US$157K | 0.76% |
| Lb Pharmaceuticals Inc | 3,779 | US$151K | 0.73% |
| Cormedix Inc. | 19,753 | US$149K | 0.72% |
| Theravance Biopharma, Inc. | 8,663 | US$146K | 0.71% |
| Aclaris Therapeutics, Inc. | 26,010 | US$135K | 0.65% |
| Phathom Pharmaceuticals, Inc. | 15,083 | US$132K | 0.64% |
| Zevra Therapeutics, Inc. | 13,272 | US$126K | 0.61% |
| Relmada Therapeutics, Inc. | 23,536 | US$125K | 0.61% |
| Aquestive Therapeutics, Inc. | 28,299 | US$105K | 0.51% |
| Fulcrum Therapeutics, Inc. | 29,016 | US$104K | 0.50% |
| Lexicon Pharmaceuticals, Inc. | 40,310 | US$93,116 | 0.45% |
| Bioage Labs, Inc. | 9,418 | US$85,139 | 0.41% |
| Evolus, Inc. Common Stock | 11,690 | US$68,270 | 0.33% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |